ALGS stock

Aligos Therapeutics Inc (ALGS) financials · rev $2.2M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Aligos Therapeutics Inc (ALGS) rev $2.2M.

Cached annual income statement
LineFY2025FY2024
Revenue$2.19M$3.61M
Operating Income-$88.0M-$89.2M
Net Income-$24.2M-$131.2M
EPS (Diluted)-$2.45-$20.94
Cached annual balance sheet
LineFY2025FY2024
Total Assets$88.5M$70.1M
Current Assets$82.9M$62.1M
Cash & Equivalents$18.3M$37.0M
PP&E$1.87M$2.36M
Total Liabilities$35.0M$99.1M
Current Liabilities$21.2M$21.7M
Shareholders' Equity$53.5M-$29.0M
Retained Earnings-$642.2M-$618.0M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$82.5M-$80.7M
CapExN/A$130.0K
Investing Cash Flow-$37.8M-$18.3M
Financing Cash Flow$101.6M$355.0K
Free Cash FlowN/A-$80.9M
These statements as JSON? API free 100/day

FAQ

What is ALGS P/E and revenue?

Aligos Therapeutics Inc (ALGS) rev $2.2M.

What is ALGS revenue?

Aligos Therapeutics Inc last cached revenue is $2.19M (FY2025).

Is ALGS profitable?

Aligos Therapeutics Inc last cached net income is -$24.2M (FY2025).

What are ALGS total assets?

Aligos Therapeutics Inc last cached total assets are $88.5M (FY2025).

What is ALGS free cash flow?

No cached cash-flow row for ALGS yet.

Not investment advice. Cached statements, not a live tape.